Clinical trial
Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid…
NCT00034203 · XOMA (US) LLC, Industry · Completed
Key facts
| NCT number | NCT00034203 |
|---|---|
| Title | Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis. |
| Lead sponsor | XOMA (US) LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | efalizumab |
| Start date | Apr 1, 2002 |
| Completion | Aug 1, 2003 |
| First posted | Apr 25, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: